M 138 M 138 (Stavudine 40 mg)
Pill with imprint M 138 M 138 is Orange, Capsule-shape and has been identified as Stavudine 40 mg. It is supplied by Mylan Pharmaceuticals Inc.
Stavudine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Stavudine 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 138 M 138
Stavudine
- Imprint
- M 138 M 138
- Strength
- 40 mg
- Color
- Orange
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
D&C Red No. 28,
D&C Yellow No. 10,
FD&C Yellow No. 6,
gelatin,
titanium dioxide,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac,
ammonia
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-5043 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 54569-6123 | A-S Medication Solutions, LLC (repackager) |
Related images for "M 138 M 138"
More about stavudine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Other brands
- Zerit
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.